KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,478,103 | -49.4% | 286,700 | -35.2% | 1.95% | -41.7% |
Q2 2023 | $95,891,070 | +30.7% | 442,200 | +9.5% | 3.35% | +37.5% |
Q1 2023 | $73,346,232 | +24.8% | 403,800 | +35.1% | 2.44% | +91.3% |
Q4 2022 | $58,753,500 | -39.5% | 299,000 | -30.8% | 1.27% | -35.5% |
Q3 2022 | $97,125,000 | +275.3% | 431,800 | +111.1% | 1.98% | +232.5% |
Q2 2022 | $25,880,000 | – | 204,570 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |